Support and services
Opportunity provides small loans and other support services to women and families in need, helping them to grow their businesses, generate sustainable income and create a brighter future for their families.
Founded in the 1970s by David Bussau, an Australian entrepreneur and one of the pioneers of microfinance, Opportunity works through local partners to provide small loans to over 6 million women in India and Indonesia, and supports other impactful community programs across Asia.
Opportunity's impact
Opportunity takes a multi-faceted approach to tackling poverty and addresses the specific needs of the people they are helping. Their support centres on four key aspects of the poverty cycle- microfinance, health, education, and women’s safety.
Microfinance
Small loans and financial services that help families start and build sustainable businesses.
Health
Community health and sanitation training that empowers women and educates communities.
Education
Financial assistance to parents and schools to improve the quality of education.
Women’s safety
Empowering women and communities through domestic violence prevention training and trafficking prevention programs.
Interested in supporting this worthy cause?
Learn more about OpportunityLearn more about our other charity partnerships
As part of our social responsibility to the broader community and our commitment to providing support to those less fortunate, RedZed has also established charity partnerships with the Lighthouse Foundation and the Royal Children’s Hospital.
Lighthouse Foundation
From the day RedZed was founded, we have supported the Lighthouse Foundation’s important work. Lighthouse provides therapeutic homes, care and tailored support programs to children and young people impacted by long-term neglect, abuse and homelessness.
Royal Children’s Hospital Neuroscience Advanced Clinical Imaging Service (NACIS)
The Royal Children’s Hospital (RCH) Neuroscience Advanced Clinical Imaging Service (NACIS) was established in January 2020 to help improve surgical outcomes in hundreds of children with drug-refractory epilepsy and brain tumours.